During the past decade, Smolensk State Medical University conducted 30 clinical trials. In the 10-year time frame, 30 clinical trials started and 23 clinical trials were completed, i.e. on average, 76.7% percent of trials that started reached the finish line to date. In the past 5 years, 15 clinical trials started and 14 clinical trials were completed. i.e. 93.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Smolensk State Medical University" #1 sponsor was "Pfizer" with 8 trials, followed by "Mannkind Corporation" with 5 trials sponsored, "Bayer" with 3 trials sponsored, "Eli Lilly and Company" with 3 trials sponsored and "Gilead Sciences" with 3 trials sponsored. Other sponsors include 23 different institutions and companies that sponsored additional 24 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Smolensk State Medical University" #1 collaborator was "Allergan" with 1 trials as a collaborator, "Biomedical Advanced Research and Development Authority" with 1 trials as a collaborator, "Datamap" with 1 trials as a collaborator, "Innovative Medicines Initiative (IMI) COMBACTE-CARE (EU)" with 1 trials as a collaborator and "Linical Co., Ltd." with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 7 trials.

According to Clinical.Site data, the most researched conditions in "Smolensk State Medical University" are "Psoriasis" (6 trials), "COVID-19" (4 trials), "Rheumatoid Arthritis" (3 trials), "Schizophrenia" (3 trials) and "Type 2 Diabetes Mellitus" (3 trials). Many other conditions were trialed in "Smolensk State Medical University" in a lesser frequency.

Most popular intervention types in "Smolensk State Medical University" are "Drug" (46 trials), "Biological" (4 trials), "Other" (4 trials), "Behavioral" (3 trials) and "Combination Product" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (23 trials), "Diet" (3 trials), "Exercise" (3 trials), "Ranolazine" (3 trials) and "ATM-AVI" (2 trials). Other intervention names were less common.

The vast majority of trials in "Smolensk State Medical University" are 47 trials for "All" genders and 3 trials for "Female" genders.

Currently, there are NaN active trials in "Smolensk State Medical University". undefined are not yet recruiting, 4 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 35 completed trials in Smolensk State Medical University, undefined suspended trials, and 7 terminated clinical trials to date.

Out of the total trials that were conducted in Smolensk State Medical University, 0 "Phase 1" clinical trials were conducted, 8 "Phase 2" clinical trials and 40 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".